Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cayman Chemical
Ann Arbor, Michigan, United Statescaymanchem.com ↗
- Ownership
- Private
- Employees
- ~400
- Development stage
- Commercial
01
Overview
Cayman Chemical provides over 15,000 life science research products including small molecules (>12k), assay kits (>3k), antibodies and recombinant proteins. The company has deep expertise in lipid chemistry—especially eicosanoids/prostaglandins—and supplies both research-use-only reagents globally as well as select clinical APIs such as Alprostadil. Its subsidiary Cayman Pharma s.r.o. manufactures pharmaceutical-grade prostaglandins for human/veterinary medicine under GMP standards.
- Therapeutic areas
- Men's HealthEndocrinologyOtherCardiovascularOphthalmology
- Modalities
- Small moleculesAssay kitsAntibodiesRecombinant proteinsAPIs (Active Pharmaceutical Ingredients)
- Industry
- Chemicals & Materials
Beyond the preview
Go deeper on Cayman Chemical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cayman Chemical.